Scholarlink

Background <p><i>DNM1L</i> encodes dynamin-related protein 1, which plays an important role in mitochondrial and peroxisomal division. The <i>DNM1L</i> mutation leads to cardiac dysfunction in patients and animal models. However, the mechanism of cardiac dysfunction caused by <i>DNM1L</i> mutation has not been elucidated clearly at least in the studies of human cardiomyocytes.</p> Methods <p>We established human induced pluripotent stem cells (hiPSCs) from two pediatric patients with <i>DNM1L</i> mutation. The hiPSCs were differentiated into hiPSC-derived cardiomyocytes (hiPS-CMs). Mitochondrial morphology and function, cardiomyocyte Ca<sup>2+</sup> dynamics, and contractile and diastolic function of hiPS-CMs were analyzed.</p> Results <p>The morphology of the mitochondria was abnormally elongated in patient-derived hiPS-CMs. The mitochondrial membrane potential and oxygen consumption rate were significantly decreased, resulting in reduced ATP production. In the analysis of Ca<sup>2+</sup> dynamics, the 50% time to decay was significantly longer in patient-derived hiPS-CMs than in healthy control. High-precision live-imaging system analysis revealed that contractile and diastolic function was significantly impaired under isoproterenol stimulation.</p> Conclusion <p><i>DNM1L</i> mutations cause mitochondrial impairment with less production of ATP in cardiomyocytes. This leads to abnormal intracellular Ca<sup>2+</sup> dynamics, resulting in contractile and diastolic dysfunction.</p> Impact <p><UnorderedList Mark="Bullet"> <ItemContent> <p><i>DNM1L</i> mutations was identified in two pediatric patients who developed cardiac dysfunction and human induced pluripotent stem cells (hiPSCs) were established from these two patients and differentiated into hiPSC-derived cardiomyocytes (hiPS-CMs).</p> </ItemContent> <ItemContent> <p><i>DNM1L</i> mutations induced abnormal mitochondrial morphology, mitochondrial dysfunction, and insufficient ATP production in hiPS-CMs. In addition, hiPS-CMs with <i>DNM1L</i> mutation showed abnormal Ca<sup>2+</sup> kinetics and impaired contractile and diastolic function.</p> </ItemContent> <ItemContent> <p>This is the first study that elucidate the mechanism of cardiac dysfunction caused by <i>DNM1L</i> mutations by using hiPSCs.</p> </ItemContent> </UnorderedList></p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Cardiac dysfunction due to mitochondrial impairment assessed by human iPS cells caused by DNM1L mutations

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年4月23日

查看全文
  • Madori T. Osawa,
  • Yasunori Fujita,
  • Kazuki Kagami,
  • Masataka Ito,
  • Yoshiteru Tamura,
  • Shoichiro Tateishi,
  • Junya Take,
  • Fumi Hirose,
  • Hidetoshi Hagiwara,
  • Kohsuke Imai,
  • Daisuke Yoshinaga,
  • Shiro Baba,
  • Mitsujiro Osawa,
  • Hiroko Harashima,
  • Kei Murayama,
  • Yuko Akioka,
  • Akira Ohtake,
  • Ikuro Suzuki,
  • Takeshi Adachi,
  • Takeru Yamazaki,
  • Satoshi Arai,
  • Shiro Matsumoto,
  • Tetsuya Kitaguchi,
  • Megumu K. Saito,
  • Ikuroh Ohsawa,
  • Shigeaki Nonoyama

摘要

Background

DNM1L encodes dynamin-related protein 1, which plays an important role in mitochondrial and peroxisomal division. The DNM1L mutation leads to cardiac dysfunction in patients and animal models. However, the mechanism of cardiac dysfunction caused by DNM1L mutation has not been elucidated clearly at least in the studies of human cardiomyocytes.

Methods

We established human induced pluripotent stem cells (hiPSCs) from two pediatric patients with DNM1L mutation. The hiPSCs were differentiated into hiPSC-derived cardiomyocytes (hiPS-CMs). Mitochondrial morphology and function, cardiomyocyte Ca2+ dynamics, and contractile and diastolic function of hiPS-CMs were analyzed.

Results

The morphology of the mitochondria was abnormally elongated in patient-derived hiPS-CMs. The mitochondrial membrane potential and oxygen consumption rate were significantly decreased, resulting in reduced ATP production. In the analysis of Ca2+ dynamics, the 50% time to decay was significantly longer in patient-derived hiPS-CMs than in healthy control. High-precision live-imaging system analysis revealed that contractile and diastolic function was significantly impaired under isoproterenol stimulation.

Conclusion

DNM1L mutations cause mitochondrial impairment with less production of ATP in cardiomyocytes. This leads to abnormal intracellular Ca2+ dynamics, resulting in contractile and diastolic dysfunction.

Impact

DNM1L mutations was identified in two pediatric patients who developed cardiac dysfunction and human induced pluripotent stem cells (hiPSCs) were established from these two patients and differentiated into hiPSC-derived cardiomyocytes (hiPS-CMs).

DNM1L mutations induced abnormal mitochondrial morphology, mitochondrial dysfunction, and insufficient ATP production in hiPS-CMs. In addition, hiPS-CMs with DNM1L mutation showed abnormal Ca2+ kinetics and impaired contractile and diastolic function.

This is the first study that elucidate the mechanism of cardiac dysfunction caused by DNM1L mutations by using hiPSCs.